子宫内膜异位症免疫方面发病机制新进展

姬 佩雲, 郝 梦启, 姚 佩佩, 张 雅丽
承德医学院附属医院

摘要

目的：子宫内膜异位症（endometriosis,EMs，简称内异症）是妇科比较多见的良性疾病，但目前其发病机制尚未完
全阐明。近几年来，由于免疫病理研究不断深入，发现了一系列与 EMs 相关的免疫细胞和分子。虽然 EMs 的确切免疫学
发病机制仍不清楚，但已有研究发现，EMs 与巨噬细胞、NK 细胞、淋巴细胞、中性粒细胞、血小板以及免疫活性分子等
多种免疫活性细胞和分子有关。因此，本文就近年来上述免疫细胞和活性分子在 EMs 中的发病机制作一综述，以期为 EMs
的免疫学诊断与靶向治疗提供新的思路。

关键词

子宫内膜异位症；发病机制；免疫细胞；免疫活性分子

参考

[1] GIANNELLA L, MARCONI C, DI GIUSEPPE J, et al. Malignant Transformation of Postmenopausal Endometriosis: A Systematic Review of the Literature [J]. Cancers (Basel), 2021, 13(16).

[2] ZONDERVAN K T, BECKER C M, KOGA K, et al. Endometriosis [J]. Nat Rev Dis Primers, 2018, 4(1): 9.

[3] A R T E M O VA D , V I S H N Y A K O VA P , KHASHCHENKO E, et al. Endometriosis and Cancer: Exploring the Role of Macrophages [J]. Int J Mol Sci, 2021, 22(10).

[4] HUDSON Q J, ASHJAEI K, PERRICOS A, et al. Endometriosis Patients Show an Increased M2 Response in the Peritoneal CD14(+low)/CD68(+low) Macrophage Subpopulation Coupled with an Increase in the T-helper 2 and T-regulatory Cells [J]. Reprod Sci, 2020, 27(10): 1920-31.

[5] VALLVé-JUANICO J, SANTAMARIA X, VO K C,et al. Macrophages display proinflammatory phenotypes in the eutopic endometrium of women with endometriosis with relevance to an infectious etiology of the disease [J]. Fertil

Steril, 2019, 112(6): 1118-28.

[6] HOGG C, PANIR K, DHAMI P, et al. Macrophages inhibit and enhance endometriosis depending on their origin [J]. Proc Natl Acad Sci U S A, 2021, 118(6).

[7] SAEKI S, FUKUI A, MAI C, et al. Co-expression of activating and inhibitory receptors on peritoneal fluid NK cells in women with endometriosis [J]. J Reprod Immunol, 2023, 155: 103765.

[8] DRURY J A, PARKIN K L, COYNE L, et al. The dynamic changes in the number of uterine natural killer cells are specific to the eutopic but not to the ectopic endometrium in women and in a baboon model of endometriosis [J]. Reprod Biol Endocrinol, 2018, 16(1): 67.

[9] B E L L E L I S P, F R E D I A N I B A R B E I R O D , GUEUVOGHLANIAN-SILVA B Y, et al. Interleukin-15 and Interleukin-7 are the Major Cytokines to Maintain Endometriosis [J]. Gynecol Obstet Invest, 2019, 84(5): 435-44.

[10] GUEUVOGHLANIAN-SILVA B Y, BELLELIS P, BARBEIRO D F, et al. Treg and NK cells related cytokines are associated with deep rectosigmoid endometriosis and clinical symptoms related to the disease [J]. J Reprod Immunol, 2018, 126: 32-8.

[11] MURATA H, TANAKA S, OKADA H. Immune Tolerance of the Human Decidua [J]. J Clin Med, 2021, 10(2).

[12] XIAO F, LIU X, GUO S W. Platelets and Regulatory T Cells May Induce a Type 2 Immunity That Is Conducive to the Progression and Fibrogenesis of Endometriosis [J]. Front Immunol, 2020, 11: 610963.

[13] O L K O W S K A - T R U C H A N O W I C Z J , BIAŁOSZEWSKA A, ZWIERZCHOWSKA A, et al. Peritoneal Fluid from Patients with Ovarian Endometriosis Displays Immunosuppressive Potential and Stimulates Th2 Response [J].

Int J Mol Sci, 2021, 22(15).

[14] VOLTOLINI VELHO R, HALBEN N, CHEKEROV R, et al. Functional changes of immune cells: signal of immune tolerance of the ectopic lesions in endometriosis? [J]. Reprod Biomed Online, 2021, 43(2): 319-28.

[15] LE MENN G, JABŁOŃSKA A, CHEN Z. The effects of post-translational modifications on Th17/Treg cell differentiation [J]. Biochim Biophys Acta Mol Cell Res, 2022, 1869(6): 119223.

[16] KHAN K N, YAMAMOTO K, FUJISHITA A, et al. Differential Levels of Regulatory T Cells and T-Helper-17 Cells in Women With Early and Advanced Endometriosis [J]. J Clin Endocrinol Metab, 2019, 104(10): 4715-29.

[17] LE N X H, LORET DE MOLA J R, BREMER P, et al. Alteration of systemic and uterine endometrial immune populations in patients with endometriosis [J]. Am J Reprod Immunol, 2021, 85(3): e13362.

[18] LE N, CREGGER M, FAZLEABAS A, et al. Effects of endometriosis on immunity and mucosal microbial community dynamics in female olive baboons [J]. Sci Rep, 2022, 12(1): 1590.

[19] KRáLíČKOVá M, FIALA L, LOSAN P, et al. Altered Immunity in Endometriosis: What Came First? [J]. Immunol Invest, 2018, 47(6): 569-82.

[20] SYMONS L K, MILLER J E, TYRYSHKIN K, et al. Neutrophil recruitment and function in endometriosis patients and a syngeneic murine model [J]. Faseb j, 2020, 34(1): 1558-75.

[21] XU H, ZHAO J, LU J, et al. Ovarian endometrioma infiltrating neutrophils orchestrate immunosuppressive microenvironment [J]. J Ovarian Res, 2020, 13(1): 44.

[22] CLOUTIER N, ALLAEYS I, MARCOUX G, et al. Platelets release pathogenic serotonin and return to circulation after immune complex-mediated sequestration [J]. Proc Natl Acad Sci U S A, 2018, 115(7): E1550-e9.

[23] MILLER J E, LINGEGOWDA H, SYMONS L K, et al. IL-33 activates group 2 innate lymphoid cell expansion and modulates endometriosis [J]. JCI Insight, 2021, 6(23).

[24] SHI J L, ZHENG Z M, CHEN M, et al. IL-17: an important pathogenic factor in endometriosis [J]. Int J Med Sci, 2022, 19(4): 769-78.

[25] MILLER J E, AHN S H, MARKS R M, et al. IL-17A Modulates Peritoneal Macrophage Recruitment and M2 Polarization in Endometriosis [J]. Front Immunol, 2020, 11: 108.

[26] HABIBI S, RAMAZANALI F, FAVAEDI R, et al. Thymic stromal lymphopoietin (TSLP) is a potent proinflammatory mediator which is epigenetically deregulated in endometriosis [J]. J Reprod Immunol, 2022, 151: 103515.

[27] YANG H L, CHANG K K, MEI J, et al. Estrogen restricts the apoptosis of endometrial stromal cells by promoting TSLP secretion [J]. Mol Med Rep, 2018, 18(5): 4410-6.

[28] SYMONS L K, MILLER J E, KAY V R, et al. The Immunopathophysiology of Endometriosis [J]. Trends Mol Med, 2018, 24(9): 748-62.

[29] REKKER K, SAARE M, ERISTE E, et al. Highthroughput mRNA sequencing of stromal cells from endometriomas and endometrium [J]. Reproduction, 2017, 154(1): 93-100.

[30] PALOMINO W A, TAYADE C, ARGANDOñA F, et al. The endometria of women with endometriosis exhibitdysfunctional expression of complement regulatory proteins during the mid secretory phase [J]. J Reprod Immunol, 2018, 125: 1-7.

[31] YU L, SHEN H, REN X, et al. Multi-omics analysis reveals the interaction between the complement system and the coagulation cascade in the development of endometriosis [J].Sci Rep, 2021, 11(1): 11926.

[32] D E B A R R O S I B L , M A LV E Z Z I H ,GUEUVOGHLANIAN-SILVA B Y, et al. “What do we know about regulatory T cells and endometriosis? A systematic review” [J]. J Reprod Immunol, 2017, 120: 48-55.

[33]ZHANG T, DE CAROLIS C, MAN G C W, et al. The link between immunity, autoimmunity and endometriosis: a literature update [J]. Autoimmun Rev, 2018, 17(10): 945-55.

[34] TOULLEC L, BATTEUX F, SANTULLI P, et al. High Levels of Anti-GM-CSF Antibodies in Deep Infiltrating Endometriosis [J]. Reprod Sci, 2020, 27(1): 211-7.